No Data
What does AI pharmaceuticals still lack before a market explosion? | Focus
① From the discovery of targets to the identification of preclinical candidate compounds, current generative AI mainly focuses on the early stages of drug development, which can lead to significant acceleration; ② If AI in drug development is to further expand the realm of possibilities, it must explore more profitable real-world applications.
Kontafarma China Holdings Limited's (HKG:1312) Price Is Right But Growth Is Lacking After Shares Rocket 30%
Konta China (01312) subsidiary company obtained temporary stay of winding-up petition pending Hong Kong legal proceedings from the Grand Court of Cayman Islands.
Jingu Finance News | konta china (01312) announced that the Cayman Islands court made a ruling last Thursday (3rd) on the application filed by its subsidiary, Fester Global, to revoke, reject, or suspend the ruling made in the Cayman Islands in 2024, pending the rulings of the 2019 Hong Kong legal proceedings and the 2021 Hong Kong legal proceedings. According to the Cayman ruling, the Cayman court has granted temporary case management suspension to the 2024 Cayman filing, pending the rulings of the Hong Kong proceedings. The group pointed out that the 2024 Cayman filing involves Active Gains Universal.
Cayman Court Grants Temporary Stay in Winding-Up Proceedings Against Kontafarma China Unit
Express News | Kontafarma China - Cayman Court Granted Temporary Case Management Stay of 2024 Cayman Petition Pending Determination of Hong Kong Proceedings
KONTA CHINA: 2024 INTERIM REPORT
